Work

Phase II Study of the Flk-1 Tyrosine Kinase Inhibitor SU5416 in Advanced Melanoma

Year: 2004

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-03-0766

Authors: Amy C. Peterson, Susan Swiger, Walter M. Stadler, Milica Medved, Greg Karczmar, Thomas F. Gajewski

Institution: University of Chicago

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2163564441

FWCI: 3.717

Cites: 30

Cited by: 68

Related to: 10